Работы, на которые ссылается эта работа

Работ: 42

Работа: The Use of Nivolumab in Colorectal Cancer with Lynch Syndrome. A Case Report

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang +32
Статья2015Цитирований: 5
ABI
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong +17
Статья2018Цитирований: 3
ABI
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith +43
Статья2017Цитирований: 2
ABI
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
John M. Carethers
Обзорная статья2015Цитирований: 2
ABI
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Fay Kastrinos
Статья2009Цитирований: 2
ABI
Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II)
Henry T. Lynch, Patrice Watson, Stephen J. Lanspa +5
Статья1988Цитирований: 2
ABI
Screening for hereditary non-polyposis colorectal cancer: A study of 22 kindreds in The Netherlands
Hans F. A. Vasen, Frieda C. A. den Hartog Jager, Fred H. Menko +1
Статья1989Цитирований: 2
ABI
Inheritance of colorectal cancer
Randall W. Burt
Статья2007Цитирований: 2
ABI
Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC)
Hye-Jung Han, Masakazu Maruyama, Shozo Baba +2
Статья1995Цитирований: 2
ABI
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations
Patrick Joost, Christina Therkildsen, Mev Dominguez–Valentin +2
Статья2015Цитирований: 2
ABI
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Hans F. A. Vasen, Jukka‐Pekka Mecklin, P. Meera Khan +1
Статья1991Цитирований: 2
ABI
Lynch syndrome in the 21st century: clinical perspectives
Ashish K. Tiwari, Hemant K. Roy, H. T. Lynch
Обзорная статья2015Цитирований: 2
ABI
Cancer Risks Associated With Germline Mutations in <emph type="ital">MLH1</emph>, <emph type="ital">MSH2</emph>, and <emph type="ital">MSH6</emph> Genes in Lynch Syndrome
Valérie Bonadona
Статья2011Цитирований: 2
ABI
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pål Møller, Toni T. Seppälä, Inge Bernstein +33
Статья2015Цитирований: 2
ABI
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs +15
Статья2017Цитирований: 2
ABI
Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)
Heinz‐Josef Lenz, Eric Van Cutsem, María Luisa Limón +15
Статья2018Цитирований: 2
ABI
Tumor Testing for Microsatellite Instability to Identify Lynch Syndrome: New Insights Into an Old Diagnostic Strategy
Matthew B. Yurgelun, Fay Kastrinos
Другое2018Цитирований: 2
ABI
Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine
Laura Valle, Eduardo Vilar, Sean V. Tavtigian +1
Обзорная статья2018Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI